Table 3.

Generic and cohort-specific clinical outcomes

Cohort	Generic outcomes
All	Descriptive measures (age, sex, living arrangements, education) Anthropometric measures (height, mass, shoe size, waist width) Health status (comorbidities, number of falls and injuries in the 12 months prior to assessment, walking aid usage and current medication) Montreal Cognitive Assessment to evaluate global cognition55 Visual Analogue Scale to measure pain during walking (0–10, from no pain to worse pain possible) Function component of the Late-Life Function and Disability Instrument to evaluate function and disability57 58
Cohort	Cohort-specific clinical outcomes
PD	Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease (PD) Rating Scale, motor part59
MS	Expanded Disability Status Scale*60
COPD	6 min walk test Recent spirometry test obtained from medical notes to characterise lung function* COPD Assessment Test61
PFF	Short Physical Performance Battery—quiet standing balance task, a five times chair-raise test, and a 4 m walk test at preferred gait speed
CHF	6 min walk test Kansas City Cardiomyopathy Questionnaire62

*Denotes measures obtained from medical records if completed within 6 months prior to assessment.

CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; MS, multiple sclerosis; PFF, proximal femoral fracture.